Versant unveils Light Horse with $62M and a partnership with Novartis

Versant Ventures’ latest biotech emerged on Thursday morning with a $62 million Series A from Bristol Myers Squibb, AbbVie and others, plus a partnership with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Analysis highlights high TBI death rates among older adults and men

A new analysis of U.S. mortality data reveals the disproportionate impact of traumatic brain injuries (TBI) on older adults, males and certain racial and ethnic

January 10, 2025

Which COVID Strain Is Expected to Take Over in the Coming Months?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

September 22, 2024

Novartis, Ionis will work together again in the next-generation cardio space

Novartis is once again teaming up with Ionis on a next-generation siRNA cardio drug, picking up another shot in an increasingly competitive space. The deal

August 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.